These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 20064719)
1. Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET. Geldenhuys WJ; Funk MO; Barnes KF; Carroll RT Bioorg Med Chem Lett; 2010 Feb; 20(3):819-23. PubMed ID: 20064719 [TBL] [Abstract][Full Text] [Related]
2. A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEET. Geldenhuys WJ; Funk MO; Awale PS; Lin L; Carroll RT Bioorg Med Chem Lett; 2011 Sep; 21(18):5498-501. PubMed ID: 21782425 [TBL] [Abstract][Full Text] [Related]
3. Identification of small molecules that bind to the mitochondrial protein mitoNEET. Geldenhuys WJ; Yonutas HM; Morris DL; Sullivan PG; Darvesh AS; Leeper TC Bioorg Med Chem Lett; 2016 Nov; 26(21):5350-5353. PubMed ID: 27687671 [TBL] [Abstract][Full Text] [Related]
4. Novel ligands that target the mitochondrial membrane protein mitoNEET. Bieganski RM; Yarmush ML J Mol Graph Model; 2011 Jun; 29(7):965-73. PubMed ID: 21531159 [TBL] [Abstract][Full Text] [Related]
5. Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders. Justin A; Mandal S; Prabitha P; Dhivya S; Yuvaraj S; Kabadi P; Sekhar SJ; Sandhya CH; Wadhwani AD; Divakar S; Bharathi JJ; Durai P; Prashantha Kumar BR Neurotox Res; 2020 Mar; 37(3):508-524. PubMed ID: 31782098 [TBL] [Abstract][Full Text] [Related]
6. mitoNEET as a novel drug target for mitochondrial dysfunction. Geldenhuys WJ; Leeper TC; Carroll RT Drug Discov Today; 2014 Oct; 19(10):1601-6. PubMed ID: 24814435 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe. Colca JR; McDonald WG; Waldon DJ; Leone JW; Lull JM; Bannow CA; Lund ET; Mathews WR Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E252-60. PubMed ID: 14570702 [TBL] [Abstract][Full Text] [Related]
9. A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates mitochondrial function in db/db mice. Takahashi T; Yamamoto M; Amikura K; Kato K; Serizawa T; Serizawa K; Akazawa D; Aoki T; Kawai K; Ogasawara E; Hayashi J; Nakada K; Kainoh M J Pharmacol Exp Ther; 2015 Feb; 352(2):338-45. PubMed ID: 25503385 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation. De Nuccio C; Bernardo A; Cruciani C; De Simone R; Visentin S; Minghetti L Exp Neurol; 2015 Sep; 271():506-14. PubMed ID: 26210873 [TBL] [Abstract][Full Text] [Related]
11. Redox characterization of the FeS protein MitoNEET and impact of thiazolidinedione drug binding. Bak DW; Zuris JA; Paddock ML; Jennings PA; Elliott SJ Biochemistry; 2009 Nov; 48(43):10193-5. PubMed ID: 19791753 [TBL] [Abstract][Full Text] [Related]
12. Reduction of mitochondrial protein mitoNEET [2Fe-2S] clusters by human glutathione reductase. Landry AP; Cheng Z; Ding H Free Radic Biol Med; 2015 Apr; 81():119-27. PubMed ID: 25645953 [TBL] [Abstract][Full Text] [Related]
13. MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Wiley SE; Murphy AN; Ross SA; van der Geer P; Dixon JE Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5318-23. PubMed ID: 17376863 [TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists. Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064 [TBL] [Abstract][Full Text] [Related]